|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
Q2 FY2021
As of Jun 30, 2021
|
Q1 FY2021
As of Mar 31, 2021
|
Q4 FY2020
As of Dec 31, 2020
|
Q3 FY2020
As of Sep 30, 2020
|
Q2 FY2020
As of Jun 30, 2020
|
Q1 FY2020
As of Mar 31, 2020
|
Q4 FY2019
As of Dec 31, 2019
|
Q3 FY2019
As of Sep 30, 2019
|
Q2 FY2019
As of Jun 30, 2019
|
Q1 FY2019
As of Mar 31, 2019
|
Q4 FY2018
As of Dec 31, 2018
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||||||||||
| Current assets: | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Accrued receivable | ||||||||||||||||||||
| Prepaid expenses | ||||||||||||||||||||
| Deposit to Acquire oil and gas property | ||||||||||||||||||||
| Total current assets | ||||||||||||||||||||
| Oil and gas properties and equipment: | ||||||||||||||||||||
| Oil and gas properties and equipment | ||||||||||||||||||||
| Accumulated depreciation, depletion and impairment | ||||||||||||||||||||
| Property and equipment, net | ||||||||||||||||||||
| Investment in unconsolidated subsidiary – GMDOC, LLC | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| LIABILITIES AND STOCKHOLDERS’ DEFICIT | ||||||||||||||||||||
| Current liabilities: | ||||||||||||||||||||
| Accounts payable | ||||||||||||||||||||
| Accrued liabilities | ||||||||||||||||||||
| Accrued interest - $2,139 and $1,501 to related parties as of September 30, 2023 and December 31, 2022, respectively | ||||||||||||||||||||
| Asset retirement obligations | ||||||||||||||||||||
| Notes payable, net | ||||||||||||||||||||
| Accrued dividends | ||||||||||||||||||||
| Warrant derivative liability | ||||||||||||||||||||
| Convertible notes payable, net of unamortized discount | ||||||||||||||||||||
| Total current liabilities | ||||||||||||||||||||
| Asset retirement obligations | ||||||||||||||||||||
| Convertible promissory notes, net of unamortized discount - related parties | ||||||||||||||||||||
| Related Party | ||||||||||||||||||||
| Total convertible promissory notes, net of unamortized discount - related parties | ||||||||||||||||||||
| Derivative liabilities | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| Stockholders’ deficit: | ||||||||||||||||||||
| Preferred stock, value | ||||||||||||||||||||
| Series A Convertible Preferred Stock | ||||||||||||||||||||
| Series B Convertible Preferred Stock | ||||||||||||||||||||
| Total preferred stock, value | ||||||||||||||||||||
| Common Stock, par value $0.0001 per share, 500,000,000 shares authorized, 24,069,515 shares issued and outstanding at September 30, 2023 and 21,924,515 shares issued and outstanding at December 31, 2022 | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Accumulated deficit | ||||||||||||||||||||
| Total stockholders’ deficit | ||||||||||||||||||||
| Total liabilities and stockholders’ deficit | ||||||||||||||||||||
Loading...
